Publications Repository

Publications Repository

View Item 
  •   Home
  • ICR Divisions
  • Genetics and Epidemiology
  • View Item
  • Home
  • ICR Divisions
  • Genetics and Epidemiology
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Analysis of Over 140,000 European Descendants Identifies Genetically Predicted Blood Protein Biomarkers Associated with Prostate Cancer Risk.

Thumbnail
View/Open
Accepted version (678.3Kb)
Publication Date
2019-09
ICR Author
Eeles, Rosalind
Kote-Jarai, Zsofia
Author
Wu, L
Shu, X
Bao, J
Guo, X
Kote-Jarai, Z
Haiman, CA
Eeles, RA
Zheng, W
PRACTICAL, CRUK, BPC3, CAPS, PEGASUS Consortia
Type
Journal Article
Metadata
Show full item record
Abstract
Several blood protein biomarkers have been associated with prostate cancer risk. However, most studies assessed only a small number of biomarkers and/or included a small sample size. To identify novel protein biomarkers of prostate cancer risk, we studied 79,194 cases and 61,112 controls of European ancestry, included in the PRACTICAL/ELLIPSE consortia, using genetic instruments of protein quantitative trait loci for 1,478 plasma proteins. A total of 31 proteins were associated with prostate cancer risk including proteins encoded by <i>GSTP1</i>, whose methylation level was shown previously to be associated with prostate cancer risk, and <i>MSMB, SPINT2, IGF2R</i>, and <i>CTSS</i>, which were previously implicated as potential target genes of prostate cancer risk variants identified in genome-wide association studies. A total of 18 proteins inversely correlated and 13 positively correlated with prostate cancer risk. For 28 of the identified proteins, gene somatic changes of short indels, splice site, nonsense, or missense mutations were detected in patients with prostate cancer in The Cancer Genome Atlas. Pathway enrichment analysis showed that relevant genes were significantly enriched in cancer-related pathways. In conclusion, this study identifies 31 candidates of protein biomarkers for prostate cancer risk and provides new insights into the biology and genetics of prostate tumorigenesis. SIGNIFICANCE: Integration of genomics and proteomics data identifies biomarkers associated with prostate cancer risk.
URL
https://repository.icr.ac.uk/handle/internal/3323
Collections
  • Genetics and Epidemiology
  • Radiotherapy and Imaging
Licenseref URL
http://www.rioxx.net/licenses/under-embargo-all-rights-reserved
Version of record
10.1158/0008-5472.can-18-3997
Subject
PRACTICAL, CRUK, BPC3, CAPS, PEGASUS Consortia
Humans
Prostatic Neoplasms
Genetic Predisposition to Disease
Blood Proteins
Risk Factors
Case-Control Studies
Genotype
European Continental Ancestry Group
Male
Genome-Wide Association Study
Biomarkers, Tumor
Research team
Oncogenetics
Language
eng
Date accepted
2019-07-17
License start date
2019-09
Citation
Cancer research, 2019, 79 (18), pp. 4592 - 4598

Browse

All of ICR repositoryICR DivisionsIssue dateAuthorsTitlesSubjectsThis collectionIssue dateAuthorsTitlesSubjects

Statistics

Most popular itemsStatistics by countryMost popular authors
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.